BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 15137989)

  • 1. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
    Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ; White BA
    J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation.
    Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M
    Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC.
    Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z
    J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
    Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
    J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of buclizine hydrochloride in pharmaceutical formulations and human serum by RP-HPLC.
    Arayne MS; Sultana N; Siddiqui FA
    Pak J Pharm Sci; 2006 Oct; 19(4):326-9. PubMed ID: 17105713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of insulin entrapment efficiency in triblock copolymeric nanoparticles by high-performance liquid chromatography.
    Xu X; Fu Y; Hu H; Duan Y; Zhang Z
    J Pharm Biomed Anal; 2006 Apr; 41(1):266-73. PubMed ID: 16303273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated stability-indicating HPLC method for the determination of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) and its degradation products.
    Hadad GM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):695-703. PubMed ID: 18403161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules.
    Mohammadi A; Haririan I; Rezanour N; Ghiasi L; Walker RB
    J Chromatogr A; 2006 May; 1116(1-2):153-7. PubMed ID: 16603170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using of HPLC coupled with coulometric detector for the determination of biotin in pharmaceuticals.
    Zerzanová A; Zizkovský V; Kucera R; Klimes J; Jesenský I; Dohnal J; Barrón D
    J Pharm Biomed Anal; 2007 Dec; 45(5):730-5. PubMed ID: 17920225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid determination of amoxicillin in premixes by HPLC.
    Dousa M; Hosmanová R
    J Pharm Biomed Anal; 2005 Feb; 37(2):373-7. PubMed ID: 15708680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.
    Bao Y; He Y; Xu X; Mo X; Xu X; Wang X; An H
    J Pharm Biomed Anal; 2008 Jan; 46(1):206-10. PubMed ID: 17964749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of alfuzosin hydrochloride in pharmaceutical formulations by RP-HPLC.
    Ganesh M; Uppatyay S; Tivari R; Kamalakannan K; Rathinavel G; Gangully S; Sivakumar T
    Pak J Pharm Sci; 2009 Jul; 22(3):263-6. PubMed ID: 19553171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
    Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
    J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products.
    Seshachalam U; Haribabu B; Chandrasekhar K
    Biomed Chromatogr; 2007 Jul; 21(7):716-23. PubMed ID: 17370253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms.
    Hadad GM; Emara S; Mahmoud WM
    Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a simple and sensitive high-performance liquid chromatography method for determination of glucosamine in pharmaceutical formulations.
    Nemati M; Valizadeh H; Ansarin M; Ghaderi F
    J AOAC Int; 2007; 90(2):354-7. PubMed ID: 17474504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection.
    Hefnawy MM; Sultan MA; Al-Shehri MM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):328-36. PubMed ID: 17681871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.